Quarterly report pursuant to Section 13 or 15(d)

Stockholders??? Deficit (Details)

v3.23.3
Stockholders’ Deficit (Details) - USD ($)
$ / shares in Units, $ in Thousands
1 Months Ended 9 Months Ended
Jul. 31, 2021
Sep. 30, 2023
Jul. 11, 2023
Dec. 31, 2022
Stockholders’ Deficit (Details) [Line Items]        
Common stock, shares authorized   200,000,000   200,000,000
Common stock, par value (in Dollars per share)   $ 0.001   $ 0.001
Exchange for cash price, per unit (in Dollars per share) $ 5      
Shares of common stock   736,773    
Convertible debt shares granted   184,193    
Common Stock [Member]        
Stockholders’ Deficit (Details) [Line Items]        
Shares issued 5,000,000      
Common stock price, per share (in Dollars per share) $ 4.99      
Series A-1 Preferred Stock [Member]        
Stockholders’ Deficit (Details) [Line Items]        
Auto-conversion of the series A-1 preferred stock     19,516,205  
Warrant [Member]        
Stockholders’ Deficit (Details) [Line Items]        
Shares issued 4,000,000      
Exercise price per warrant (in Dollars per share) $ 0.0125 $ 6    
Warrants term 5 years 5 years    
Exercise price per share (in Dollars per share) $ 6      
Purchase of additional warrants 600,000      
Proceeds of warrants (in Dollars) $ 7,500